GGrantIndex
← Leaderboards

Masakazu Kamata

University Of California Los Angeles

$5,573,549
Attributed
$5,573,549
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $936.6K · FY201625
$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,573,549 · 4

By mechanism

R01$5,165,174 · 3
R21$408,375 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Novel Strategies

Research focus

Novel StrategiesCellsIn VivoMouse ModelPropertyResponseImmune ResponseHumanized MouseLocationBrainAntibodiesPenetrationPharmaceutical PreparationsMaintenanceNanocapsuleBaseSignal TransductionAnti-CancerAffinityMalignant NeoplasmsMonoclonal AntibodiesGenesEnsureBlood - Brain Barrier Anatomy

Grant awards (14)

The resurgence of antibody-drug conjugates via PMPC-polymer engineering$585,228
R01 · FY2025 · CA · contact PI
The resurgence of antibody-drug conjugates via PMPC-polymer engineering$585,228
R01 · FY2024 · CA · contact PI
Eradication of brain/CNS HIV reservoirs via anti-HIV gene-modified macrophages$185,625
R21 · FY2023 · MH · contact PI
Nanodelivery platform for antibody drugs targeting NHL$452,835
R01 · FY2022 · CA · contact PI
Eradication of brain/CNS HIV reservoirs via anti-HIV gene-modified macrophages$222,750
R21 · FY2022 · MH · contact PI
Nanodelivery platform for antibody drugs targeting NHL$463,906
R01 · FY2021 · CA · contact PI
Nanodelivery platform for antibody drugs targeting NHL$489,135
R01 · FY2020 · CA · contact PI
Nanodelivery platform for antibody drugs targeting NHL$497,264
R01 · FY2019 · CA · contact PI
Gene-Engineered Stem Cell Memory T-Cells With Anti-HIV Chimeric Antigen Receptors$327,432
R01 · FY2019 · AI · contact PI
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors$57,568
R01 · FY2019 · AI · contact PI
Nanodelivery platform for antibody drugs targeting NHL$551,578
R01 · FY2018 · CA · contact PI
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors$385,000
R01 · FY2018 · AI · contact PI
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors$385,000
R01 · FY2017 · AI · contact PI
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors$385,000
R01 · FY2016 · AI · contact PI